HealthCor Management L.P. Increases Stock Holdings in Inspire Medical Systems, to $882,000
June 17, 2023
☀️Trending News
HealthCor Management L.P. has made a significant investment in Inspire Medical Systems ($NYSE:INSP), Inc., increasing their stock holdings to $882,000. This is a strong sign of confidence in the company. Inspire Medical Systems, Inc., is a medical technology company that specializes in the design, development, and commercialization of innovative treatments for patients who suffer from sleep apnea. The company’s products are designed to provide non-invasive treatment options for individuals who cannot tolerate traditional CPAP therapy or do not respond to it. Inspire Medical Systems, Inc., also has a portfolio of intellectual property including patents and trademarks. The company is backed by leading investors and healthcare institutions, such as Accel Partners, Apex Venture Partners, Mayo Clinic Ventures, and Synergy Life Science Partners.
In addition, they have strategic partnerships with leading healthcare providers and insurers to offer their innovative treatments to a larger patient population. This latest investment from HealthCor Management L.P. is seen as a clear sign that the company’s products and services are in high demand and that they have a bright future ahead of them. With this new capital, Inspire Medical Systems, Inc. will be able to continue to develop innovative treatments for sleep apnea patients and expand their reach into larger markets.
Share Price
This increase is quite significant, as the stock opened at $307.6 and closed at $305.2, representing a decrease of 1.3% from its prior closing price of 309.2. This news was followed by a slight decrease in stock price of the company, which could potentially indicate that the investors are hesitant towards increasing their holdings in the company given the current market trends. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for INSP. More…
| Total Revenues | Net Income | Net Margin |
| 466.37 | -43.61 | -9.4% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for INSP. More…
| Operations | Investing | Financing |
| 11.57 | -19.6 | 235.08 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for INSP. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 571.85 | 67.2 | 17.32 |
Key Ratios Snapshot
Some of the financial key ratios for INSP are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 74.9% | – | -8.9% |
| FCF Margin | ROE | ROA |
| 0.5% | -5.2% | -4.6% |
Analysis
GoodWhale conducted a detailed analysis of INSPIRE MEDICAL SYSTEMS’s wellbeing and the assessment yielded some interesting results. Our Risk Rating algorithm evaluated the company from a financial and business standpoint, and the results showed INSPIRE MEDIAL SYSTEMS to be a high risk investment. To further break down the evaluation, we detected four risk warnings in the income sheet, balance sheet, cashflow statement, and non-financial elements. To get a more detailed view of these risk warnings, we encourage users to register with GoodWhale and access our detailed analytics. More…
Peers
The company’s competitors include ShockWave Medical Inc, InMode Ltd, and INVO Bioscience Inc.
– ShockWave Medical Inc ($NASDAQ:SWAV)
ShockWave Medical Inc is a medical device company that uses shockwave technology to treat cardiovascular disease. The company has a market cap of 9.73B as of 2022 and a return on equity of 19.56%. The company’s products are used to treat a variety of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and heart failure.
– InMode Ltd ($NASDAQ:INMD)
InMode Ltd is a medical technology company that develops and manufactures minimally invasive aesthetic solutions. The company has a market capitalization of $2.71 billion as of 2022 and a return on equity of 41.58%. InMode’s products are used by physicians and patients in over 90 countries and the company has a strong presence in the United States, Europe, Asia, and Latin America. InMode’s products are backed by clinical research and have been featured in numerous peer-reviewed journals.
– INVO Bioscience Inc ($NASDAQ:INVO)
INVO Bioscience Inc is a medical device company that has developed a patented in vivo intravaginal culture (IVC) system, which is used to treat infertility. The company’s IVC system is designed to provide a more natural environment for embryo development and is intended to improve the success rates of in vitro fertilization (IVF). INVO Bioscience’s IVC system is currently being used at fertility clinics in the United States and Europe.
Summary
HealthCor Management L.P. has a total stock holdings of $882,000 in Inspire Medical Systems, Inc. (INSPIRE). INSPIRE is a medical technology company focused on the development and commercialization of minimally invasive solutions for treating obstructive sleep apnea (OSA). In addition, INSPIRE has a robust pipeline of innovative products, including the world’s only implantable neurostimulation system for OSA, which has the potential to significantly expand the addressable market for the company.
However, INSPIRE currently has no approved products in the US or Europe, and its operating costs have been increasing as it expands its sales and marketing efforts. As such, investors should carefully evaluate potential risks and evaluate the company’s progress in obtaining regulatory approvals and bringing products to market.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
